On-Site HOCl Generation

Nature’sUltimateDisinfectant,Generated On-Site.

Harnessing the biological power of Hypochlorous Acid (HOCl) to eradicate 99.999% of pathogens — safely, sustainably, and without the supply chain.

On-Site Generator · Live
pH 5.0 – 6.5
The Pure2Cure Advantage

On-site generation, end-to-end.

A vertically integrated chemistry plant the size of an appliance — installed where the disinfectant is actually needed.

Tuned pH 5.0 – 6.5

Our on-site generators produce HOCl in the precise pH window where the molecule's germicidal potency is highest and skin-compatibility is preserved.

Reduced Costs

Generating at the point of use eliminates heavy supply chain expenses — shipping water, packaging, and warehousing of pre-mixed chemistries.

Consistent Potency

Freshly generated HOCl bypasses the natural decay of bottled product, ensuring maximally effective disinfection at every dispense.

Eco-Friendly

Drastically reduced single-use packaging, no chemical drum returns, and no toxic runoff. Salt, water and electricity in — pure disinfectant out.

Manufacturing Showcase

Inside the production floor.

Operational footage from our manufacturing infrastructure — pumps, containment systems, and the catalytic chemistry that makes Pure2Cure possible.

Clip 01 · 4K

Containment Fill Cycle

High-volume pumps feeding the primary reactor vessel. Brine in, pure HOCl out — at a tuned pH of 5.0–6.5.

In-theatre disinfection

Clinical Deployment

In-theatre disinfection

The Pure2Cure unit installed beside a sterile field — generator-to-patient in one step.

Telemetry-aware units

Connected Fleet

Telemetry-aware units

Each generator reports ORP, pH and throughput in real time.

Biomimicry at its finest

The molecule your immune system already trusts.

HOCl is the exact compound human neutrophils produce to destroy pathogens. Pure2Cure replicates this cellular weapon at industrial scale.

The full physiological cycle of HOCl: immune defense, inflammation, and taurine scavenging.
The complete cycleImmune defense → inflammation control → endogenous taurine scavenging

01 · Activation

Neutrophils Engulf

Invading bacteria are captured inside a specialized compartment — the phagosome — isolating the threat from healthy tissue.

Resting vs. activated neutrophil showing NADPH oxidase assembly and phagosome formation.

02 · Respiratory Burst

NADPH Oxidase Fires

The NADPH oxidase enzyme complex generates a flood of superoxide radicals — the first oxidative weapon released into the phagosome.

Scanning electron micrograph of a neutrophil consuming bacteria, with ROS generation inset.

03 · Synthesis

Manufacturing HOCl

Superoxide Dismutase converts superoxide into hydrogen peroxide. Myeloperoxidase (MPO) then combines H₂O₂ with chloride ions and protons to manufacture HOCl, annihilating the pathogen.

Mechanism of HOCl generation in activated neutrophils.

04 · Safety

Taurine Scavenging

The body uses endogenous Taurine to quench any excess HOCl, converting it to less toxic Taurine Chloramine — preventing chronic inflammation.

Physiological vs. pathological roles of HOCl and the endogenous antioxidant defense via taurine.
Clinical Validation

Proven in the lab. By name. By pathogen.

Independent laboratories have tested the Pure2Cure HOCl solution against the pathogens that matter most. Pick a study to see the results.

Verified

Baruch Padeh Medical Center

Lead: Dr. Avi Peretz

“No growth” at 3 minutes across the most dangerous hospital-acquired pathogens.

Read the full study
PathogenResultTime / Conditions
Pseudomonas aeruginosa
gram-negative
No growth3 min
Acinetobacter baumanii
gram-negative
No growth3 min
MRSA
methicillin-resistant S. aureus
No growth3 min
Candida albicans
fungal
No growth3 min

99.999%

Pathogen kill rate

2 min

Viral neutralization

3 min

Superbug eradication

> 5 log

Bacterial reduction

Unmatched Efficacy

HOCl vs. the legacy chemicals.

Pure2Cure HOCl eliminates gram-positive and gram-negative bacteria, enveloped and non-enveloped viruses, fungi, and bacterial spores — without the trade-offs of legacy disinfectants.

AttributePure2Cure HOClChlorine Bleach
Kills 99.999% (incl. spores)YesVariable
Safe on skin / woundsYesCorrosive
Contact timeSeconds5–10 min
Odor & fumesNeutralHarsh
Eco footprintLowHigh
Efficacy of HOCl vs. chlorine bleach, alcohol-based disinfectants, and quaternary ammonium compounds across bacteria, viruses, and fungi.
Pathogen-class efficacy at a glanceHOCl achieves high efficacy across every category — bacteria, viruses, and fungi.
Human-Safe by Design

Lethal to pathogens. Gentle on people.

HOCl matches the chemistry your immune system already trusts — so it can be deployed in schools, hospitals, kitchens, and high-traffic public spaces without the trade-offs of legacy disinfectants.

HOCl vs alternative disinfectants safety comparison.
HOCl-safe vs hazardous chemistry comparison.
Pure2Cure HOCl
Legacy chemistry
Non-toxic to humans
No harsh odors or fumes
Safe on skin & eyes
Safe for all ages

Drag the divider to compare a Pure2Cure deployment against legacy chlorine, alcohol and quaternary ammonium chemistries.

Strategic Use Cases

Industries already moving to HOCl.

From the security line at the airport to the export-ready cold chain — Pure2Cure replaces brittle, imported chemistries with on-site, human-safe generation.

Case study

Aviation & Airports

Replacing toxic bleach in security trays and cabins.

Airport plastic trays carry more viruses than toilet surfaces — yet are still cleaned with corrosive bleach and quaternary ammonium compounds that damage equipment and harm passengers. Pure2Cure’s on-site generators produce 12 L/min of human-safe HOCl right where it’s needed.

  • Eliminates toxic chemistry from passenger-contact surfaces
  • On-site output of 12 L/min — eliminates logistics & storage
  • Non-corrosive to plastics, screens and aircraft interiors

12 L/min

On-site output

0

Toxic residue

Request the deck
Case study

Modernizing Agriculture

National biosecurity, without imported chemicals.

Pure2Cure equips the agricultural value chain with a domestically generated, food-safe disinfectant — preventing spoilage, ensuring export readiness and advancing national biosecurity without reliance on foreign chemical supply chains.

  • Strengthens national biosecurity posture
  • Cuts spoilage at every node of the cold chain
  • Export-ready: leaves zero chemical residue or off-flavor

100%

Domestic supply

Zero

Residue

Request the deck
Global Markets

A $5.8B → $8.5B opportunity.

The global HOCl market is expanding at a 5.6–6.3% CAGR — driven by demand for non-toxic, broad-spectrum disinfection across the most regulated industries on earth.

Global HOCl market visualization with Pure2Cure generator and sector breakdown.

Market Outlook

One molecule. Every regulated industry.

Today

$5.8B

2030

$8.5B

CAGR

5.6 – 6.3%

Healthcare & Wound Care

Hospital surface disinfection, surgical irrigation, chronic wound debridement — all with skin-safe chemistry.

Clean Beauty & Dermatology

Acne, eczema and post-procedure care formulations powered by stabilized hypochlorous acid.

Food Safety

Produce wash, processing line CIP, and cold-chain sanitation that leaves no residue or off-flavor.

Industrial & Agriculture

Livestock biosecurity, greenhouse hydroponics, cooling-tower water treatment, and beyond.

Leadership

The team behind Pure2Cure.

Surgeons, chemists, and operators with deep medical, academic and FMCG experience — translating the immune system’s own chemistry into industrial-scale impact.

Dr. Boris Orkin, MD

Dr. Boris Orkin, MD

  • CEO, Pure2Cure Ltd.
  • Head of Urology & Pediatric Surgery Unit, MHMC
  • Professional Lecturer, Dept. of Digital Medicine, HIT — Holon Institute of Technology

Pediatric surgeon and former Head of Pediatric Surgery at Kaplan, Mayane Haeshua, and Assuta Ashdod medical centers. Founded Pure2Cure in 2023 after decades on the front line of surgical infection control.

Pure2Cure · Co-Founder
Prof. Doron Aurbach

Prof. Doron Aurbach

Co-Founder

Bar-Ilan University

Internationally recognized electrochemistry researcher anchoring the academic foundation behind Pure2Cure’s on-site generation platform.

Pure2Cure · Co-Founder
Dr. Eran Avraham

Dr. Eran Avraham

Co-Founder & Chief Scientific Officer

Bar-Ilan University

Ph.D. chemist and senior lecturer at Bar-Ilan University. Leading expert in electrochemistry and water technologies, with 10+ patents bridging academic research and sustainable industrial chemistry.

Pure2Cure · Co-Founder
Dr. Izaak Cohen

Dr. Izaak Cohen

Co-Founder & CTO

Bar-Ilan University collaboration

Chief Technology Officer leading the Bar-Ilan University collaboration on HOCl generation chemistry and electrochemical cell design.

Pure2Cure · Co-Founder
Itzik Moshel

Itzik Moshel

Co-Founder

FMCG · 30+ years

Brings 30+ years of FMCG leadership. Former CEO of Maya Foods Industries and a 21-year tenure in senior management at Tnuva, including VP Marketing & Sales for the Food Division.

Pure2Cure · Co-Founder
Clinical Literature

Six papers worth your afternoon.

The most-cited peer-reviewed research and regulatory validation behind Pure2Cure — curated for clinicians, food-safety leaders, and operators.

Medical12 min · 2020

Hypochlorous Acid: A Review

A clinical review of HOCl as an inexpensive, non-toxic, and effective sanitizer against SARS-CoV-2 — covering production, stability, application methods, and oral-maxillofacial use.

  • HOCl inactivates a variety of viruses including coronaviruses in <1 min
  • 200 ppm decontaminates surfaces in 1 min; 20 ppm in 10 min
  • Endogenous to neutrophils — safe for skin, mucosa, and food contact
  • On-site generation eliminates supply-chain and shelf-life issues
Journal of Oral & Maxillofacial SurgeryRead full article
Medical18 min · 2025

Hypochlorous Acid (HOCl) as a Promising Respiratory Antiseptic

A peer-reviewed exploration of HOCl-based nasal sprays, mouthwashes, and inhalation for bacterial and viral respiratory infections — RSV, influenza, and SARS-CoV-2.

  • Aerosolized HOCl up to ~26 ppm shown safe for respiratory tissue in vitro
  • Cleaves solvent-exposed disulfide bridges (C480–C488) in SARS-CoV-2 RBD
  • Influenza A strains more susceptible than SARS-CoV-2 to low-dose HOCl
Viruses (MDPI)Read full article
Food & Ag22 min · 2005

Applications of Electrolyzed Water in Agriculture & Food Industries

A comprehensive review of HOCl/electrolyzed water across the farm-to-table chain — seed disinfection, irrigation, post-harvest washing, food contact surface sanitation, and aerial fungicide spraying.

  • HOCl is FDA-permitted for processing meat, poultry, fish, fruits, and vegetables
  • 50 ppm AEW achieves ≥7-log E. coli O157:H7 kill in 1 min at 45 °C
  • Effective against thin-walled fungi (Botrytis, Monilinia) in <30 seconds
Food Science & Technology ResearchRead full article
Lab Results14 min · 2024

Issues Surrounding the Stability of Hypochlorous Acid as a Disinfectant

Examines why bottled HOCl degrades — pH, temperature, UV exposure, organic load, and metal ions — and why on-site generation is the only way to guarantee fresh, potent disinfectant at the point of use.

  • pH 5.0–6.5 is the optimal stability + potency window
  • Above 25 °C, HOCl degrades into less-effective hypochlorite
  • UV/sunlight causes photolysis; storage must be dark and cool
  • On-site generation is the most reliable mitigation strategy
Preprints.orgRead full article
Medical10 min · 2021

A Potential Benefit of Hypochlorous Acid — Facial Sanitisation

Argues for HOCl as a facial sanitizer — covering its anti-inflammatory action, dermatological benefits, biofilm disruption, and safety on eyelids, lips, and even infant skin.

  • Endogenously produced by neutrophils — body has antioxidant defense to safely scavenge
  • Mayo Clinic SkinSafe: hypoallergenic, eyelid/lip-safe, safe for babies
  • Anti-inflammatory: reduces IL-6 cytokine binding to its receptor
Preprints.orgRead full article
Lab Results8 min · 2024

WHO Expert Committee Review on Hypochlorous Acid

Global regulatory validation: the WHO Expert Committee recommends adding HOCl to the Essential Medicines List for antisepsis, citing its superiority over povidone-iodine in safety, efficacy, and biofilm activity.

  • FDA-approved for food contact, high-level disinfection, and wound care
  • EMA-approved as Class III medical device for wound management
  • Strong evidence for diabetic foot wounds; moderate for septic surgery
WHO 25th Expert Committee on Essential MedicinesRead full article

The full Pure2Cure research library

16 papers, lab reports, and market briefings — categorized and reading-time tagged.

Open the research hub